Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women

The objective was to evaluate whether routine aspirin 75 mg is more cost-effective than the Fetal Medicine Foundation screen-and-treat approach for preeclampsia prevention in low-risk nulliparous women. A health economic decision analytical model was devised to estimate the discounted net health and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hypertension (Dallas, Tex. 1979) Tex. 1979), 2018-12, Vol.72 (6), p.1391-1396
Hauptverfasser:	Mone, Fionnuala, O'Mahony, James F, Tyrrell, Ella, Mulcahy, Cecilia, McParland, Peter, Breathnach, Fionnuala, Morrison, John J, Higgins, John, Daly, Sean, Cotter, Amanda, Hunter, Alyson, Dicker, Patrick, Tully, Elizabeth, Malone, Fergal D, Normand, Charles, McAuliffe, Fionnuala M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin - therapeutic use Cost-Benefit Analysis Female Humans Mass Screening Models, Theoretical Platelet Aggregation Inhibitors - therapeutic use Pre-Eclampsia - diagnosis Pre-Eclampsia - prevention & control Pregnancy Prenatal Care Quality-Adjusted Life Years
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!